amrinone has been researched along with Bradycardia in 1 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
Bradycardia: Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tuncok, Y | 1 |
| Apaydin, S | 1 |
| Kalkan, S | 1 |
| Ates, M | 1 |
| Guven, H | 1 |
1 other study available for amrinone and Bradycardia
| Article | Year |
|---|---|
The effects of amrinone and glucagon on verapamil-induced cardiovascular toxicity in anaesthetized rats.
Topics: Amrinone; Animals; Blood Pressure; Bradycardia; Calcium Channel Blockers; Cardiovascular Diseases; D | 1996 |